In the past four decades, there has been a significant increase in survival among people with CF due to the adoption of a multidisciplinary approach to care, aggressive antibiotic therapy, newborn screening, nutrition, addressing extrapulmonary symptoms and the recent availability of cystic fibrosis transmembrane conductance regulator (CFTR) modulators in some countries. Here, CFTR is linked to cystic fibrosis.